Coronavirus: COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
A new viral outbreak is testing whether the world has learned anything from COVID.
As COVID numbers tick up, hospitals are supposed to be ready to jump in as needed. Only, they never really had a reprieve.
Experts are expected to choose a vaccine recipe for the fall, when Omicron may or may not still be the globe’s dominant variant.
Bill Gates has a strategy to save the world from the next infectious threat. He’s not the first.
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet.
“I imagine this is what grapefruit juice mixed with soap would taste like.”
Compared with what the U.S. saw in January, the current rise in cases so far looks pretty chill. Is it, though?
With time and effort, we can build enough protection to blunt surges—but herd immunity remains out of reach.
A lot has changed since last year’s pre-Delta lull, but America can still reclaim some coronavirus-free chill—if it decides to commit.
Your pandemic reflections
Millions of people are still mourning loved ones lost to COVID, their grief intensified, prolonged, and even denied by the politics of the pandemic.
If it feels like the vibe shifted to existential despair, you’re not alone. But it won’t always be this way.
Months of confusing messaging, piled onto existing inequities, kneecapped America’s booster campaign before it had really started.
Millions of residents have been confined to their homes for weeks as Chinese authorities have taken a zero-tolerance approach to COVID-19.
The United States could be in for a double whammy: a surge it cares to neither measure nor respond to.
After a stellar run in adult and teen trials, the vaccines are now trying to contend with Omicron, and the numbers show it.
Whenever it arrives, the next surge could put the country’s tolerance for disease and death in full relief.
The successes and failures of annual flu-shot campaigns hold lessons for the future of COVID vaccines.
All epidemics trigger the same Sisyphean cycle of panic and neglect. Even so, that cycle isn’t meant to spin this quickly.
We’re tracking how the virus is changing over time. Why not monitor immunity too?